Tenon Medical Inc

For the period ended Sep 30, 2024. Filed Nov 14, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 14, 2024

TNON$1.74-0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations and Comprehensive Loss

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(In thousands, except per share data)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2024	2023	2024	2023
Revenue	$887	$944	$2,507	$2,120
Cost of sales	469	409	1,149	1,438
Gross Profit	418	535	1,358	682
Operating Expenses
Research and development	657	737	2,034	2,472
Sales and marketing	1,212	1,527	4,041	5,436
General and administrative	1,764	1,649	5,876	5,360
Total Operating Expenses	3,633	3,913	11,951	13,268
Loss from Operations	(3,215)	(3,378)	(10,593)	(12,586)
Other Income (Expense)
Gain on investments	31	50	97	143
Interest expense	—	(4)	(34)	(4)
Other income (expense), net	—	—	(56)	—
Total Other Income (Expense), net	31	46	7	139
Net Loss	$(3,184)	$(3,332)	$(10,586)	$(12,447)
Net Loss Per Share of Common Stock
Basic and diluted	$(3.63)	$(11.69)	$(18.60)	$(63.18)
Weighted-Average Shares of Common Stock Outstanding
Basic and diluted	877	285	569	197
Consolidated Statements of Comprehensive Loss:
Net loss	$(3,184)	$(3,332)	$(10,586)	$(12,447)
Unrealized gain on investments	—	—	—	16
Foreign currency translation adjustment	—	(30)	46	(18)
Total comprehensive loss	$(3,184)	$(3,362)	$(10,540)	$(12,449)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.